A detailed history of Claris Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Claris Advisors, LLC holds 125 shares of MRK stock, worth $12,421. This represents 0.01% of its overall portfolio holdings.

Number of Shares
125
Holding current value
$12,421
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$111.15 - $128.97 $13,893 - $16,121
125 New
125 $14,000
Q3 2022

Nov 01, 2022

SELL
$84.53 - $94.96 $14,370 - $16,143
-170 Reduced 5.93%
2,697 $232,000
Q2 2022

Jul 28, 2022

BUY
$83.49 - $94.64 $14,193 - $16,088
170 Added 6.3%
2,867 $261,000
Q4 2021

Jan 28, 2022

BUY
$72.28 - $90.54 $194,939 - $244,186
2,697 New
2,697 $207,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Claris Advisors, LLC Portfolio

Follow Claris Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claris Advisors, LLC , based on Form 13F filings with the SEC.

News

Stay updated on Claris Advisors, LLC with notifications on news.